Cradle

Amsterdam, Netherlands
VISIT WEBSITE
Cradle is a biotechnology company that develops an enterprise-grade AI software platform designed to accelerate protein engineering. By leveraging machine learning models, the company helps scientists in pharmaceutical, industrial, and food-tech sectors design high-performing proteins, antibodies, and enzymes, significantly reducing R&D timelines and costs. The company operates a wet lab in Amsterdam to validate its AI-generated designs, ensuring that the platform's predictions are effective in real-world applications. Cradle serves major global pharmaceutical companies and has established key collaborations, such as with Bayer, to enhance AI-enabled antibody discovery and optimization.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:AI-driven protein engineering
SIZE & FINANCIALS
Employees:51-200
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$103M
Investors:Index Ventures, IVP, Kindred Capital, Day One Ventures, Amino Collective
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Software platform provider)
Modalities:Proteins, Antibodies, Enzymes
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bayer (Collaboration for AI-enabled antibody discovery and optimization)
COMPETITION
Position:Emerging
Competitors:Generate Biomedicines, Nimbus Therapeutics, Profluent Bio, Cyrus Bio
LEADERSHIP
Key Executives:
Stef van Grieken - CEO & Co-Founder
Jelle Prins - Co-Founder
Scientific Founders:Stef van Grieken, Jelle Prins, Elise de Reus, Eli Bixby, Harmen van Rossum
LINKS
Website:cradle.bio
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Cradle and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cradle. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.